We found that CD19+ B cells and CD3+ T cells were increased in the meninges of progressive MS donors, while the levels of meningeal IBA1+ myeloid cells remained unchanged (Fig. 3a, b and Online Resource 3a). This evidence concerns the gene AIF1 and myeloid sarcoma.